Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bhargavi Thalluri
Institution:
University of Tennessee Health Science Center
Observed institution:
University of Tennessee Health Science Center
ORCID:
0009-0000-9180-4888
Observed ORCID:
0009-0000-9180-4888
OpenAlex ID:
A5098769705
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
2024
·
Damilola Oluwalana
, Kelli L. Adeleye
, et al.
·
Cancer Letters
·
5
PDF
Learnings from Approved Antibody‐Drug Conjugates: Clinical Pharmacology Perspectives
2026
·
Bhargavi Thalluri
, Aarti Sawant
, et al.
·
The Journal of Clinical Pharmacology
·
4
Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approach
2026
·
Hyunseo Park
, Amarinder Singh
, et al.
·
Frontiers in Tuberculosis
·
1
PDF
A Population PK Approach to Evaluate Plasma and ELF Exposure Changes Following Co-administration of Spectinamide 1599 and Pyrazinamide in Mice
2026
·
Bhargavi Thalluri
, Mercedes Gonzalez-Juarrero
, et al.
PDF
Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessus
2025
·
Gregory A. Phelps
, Sinem Kurt
, et al.
·
Nature Microbiology
Show more works
View as search
Works count:
5
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type